Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. dr. Koen Raemdonck

Faculty of Pharmaceutical Sciences > Department of Pharmaceutics

Work address: Ottergemsesteenweg 460
9000 Gent
Email: Koen.Raemdonck@UGent.be
ORCID iD: 0000-0002-9807-4715

Show Sort by

Add to list
- Journal Article
- A1
- open access
A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs

Bram Bogaert (UGent) , Felix Sauvage, Roberta Guagliardo, Cristina Muntean (UGent) , [missing] Van Phuc Nguyen, Eline Pottie (UGent) , Mike Wels (UGent) , An-Katrien Minnaert (UGent) , Riet De Rycke (UGent) , Qiangbing Yang, et al.

(2022) JOURNAL OF CONTROLLED RELEASE. 350. p.256-270
Add to list
- Conference Paper
- C3
- open access
Investigating membrane curvature and composition effect on membrane permeability by counting permeant crossings

Samaneh Davoudi (UGent) , Koen Raemdonck (UGent) , Kevin Braeckmans (UGent) and An Ghysels (UGent)

(2022) Molecular Simulation 2022 : present, past and future, Abstracts.
Add to list
Non-viral siRNA delivery to T cells : challenges and opportunities in cancer immunotherapy

Jelter Van Hoeck, Kevin Braeckmans (UGent) , Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)

(2022) BIOMATERIALS. 286.
Add to list
Understanding membrane permeability of drug releasing liposomes from molecular dynamics simulations : effect of curvature and composition

Samaneh Davoudi (UGent) , Koen Raemdonck (UGent) , Kevin Braeckmans (UGent) and An Ghysels (UGent)

(2022) OncoPoint Symposium, 8th, Abstracts.
Add to list
- Conference Paper
- C3
- open access
Counting permeant crossings to assess the effect of membrane curvature and composition on the permeability rate

Samaneh Davoudi (UGent) , Koen Raemdonck (UGent) , Kevin Braeckmans (UGent) and An Ghysels (UGent)

(2022) BIOPHYSICAL JOURNAL. 121(3). p.71a-72a
Add to list
- Journal Article
- A1
- open access
Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics

Thijs Van de Vyver, Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)

(2022) ADVANCED DRUG DELIVERY REVIEWS. 181.
Add to list
- Journal Article
- A1
- open access
Plasma membrane perforation by GSDME during apoptosis-driven secondary necrosis

Elke De Schutter, Jana Ramon (UGent) , Benjamin Pfeuty, Caroline De Tender (UGent) , Stephan Stremersch (UGent) , Koen Raemdonck (UGent) , Ken Op de Beeck, Wim Declercq (UGent) , Franck Riquet (UGent) , Kevin Braeckmans (UGent) , et al.

(2022) CELLULAR AND MOLECULAR LIFE SCIENCES. 79(1).
Add to list
Non-invasive cell-tracking methods for adoptive T cell therapies

Jelter Van Hoeck, Christian Vanhove (UGent) , Stefaan De Smedt (UGent) and Koen Raemdonck (UGent)

(2022) DRUG DISCOVERY TODAY. 27(3). p.793-807
Add to list
- Journal Article
- A1
- open access
Increasing angiogenesis factors in hypoxic diabetic wound conditions by siRNA delivery : additive effect of LbL-gold nanocarriers and desloratadine-induced lysosomal escape

Elnaz Shaabani Sichani (UGent) , Maryam Sharifiaghdam (UGent) , Joris Lammens (UGent) , Herlinde De Keersmaecker (UGent) , Chris Vervaet (UGent) , Thomas De Beer (UGent) , Elahe Motevaseli, Mohammad Hossein Ghahremani, Parvin Mansouri, Stefaan De Smedt (UGent) , et al.

(2021) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 22(17).
Add to list
Non-viral transfection technologies for next-generation therapeutic T cell engineering

Laurens Raes, Stefaan De Smedt (UGent) , Koen Raemdonck (UGent) and Kevin Braeckmans (UGent)

(2021) BIOTECHNOLOGY ADVANCES. 49.

1
2
3
4
…
9
10

Next →